Eli Lilly (LLY) PT Raised to $315 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,409.38 --0%
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
Mizuho Securities analyst Vamil Divan raised the price target on Eli Lilly (NYSE: LLY) to $315.00 (from $293.00) while maintaining a Buy rating.
You May Also Be Interested In
- Eli Lilly (LLY) PT Raised to $1,600 at Cantor Fitzgerald
- Pfizer (PFE) PT Raised to $30 at UBS
- Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR56 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
